Paper Details
- Home
- Paper Details
Enrofloxacin and Toltrazuril Are Able to Reduce <i>Toxoplasma gondii</i> Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy.
Author: Dos SantosMaria C, FerroEloisa A V, FiorenzaniPaolo, FrancoPriscila S, GomesAngelica O, MilianIliana C B, MineoJosé R, PereiraAriane S, RibeiroMayara, da SilvaNeide M, da SilvaRafaela J, de Freitas BarbosaBellisa
Original Abstract of the Article :
Classical treatment for congenital toxoplasmosis is based on combination of sulfadiazine and pyrimethamine plus folinic acid. Due to teratogenic effects and bone marrow suppression caused by pyrimethamine, the establishment of new therapeutic strategies is indispensable to minimize the side effects ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526852/
データ提供：米国国立医学図書館（NLM）
New Hope for Congenital Toxoplasmosis: Enrofloxacin and Toltrazuril Show Promise
The world of infectious diseases is a vast desert, filled with challenges and mysteries. This study focuses on the fight against congenital toxoplasmosis, a parasitic infection that can have devastating consequences for newborns. It's like searching for a way to protect a young camel from the dangers lurking in the dunes.
The study investigates the potential of two drugs, enrofloxacin and toltrazuril, to control the growth of Toxoplasma gondii, the parasite responsible for toxoplasmosis. This is like finding new weapons in the fight against a dangerous predator in the desert. The results are promising, showing that these drugs can effectively reduce parasite growth in human cells, potentially paving the way for new treatment options.
New Treatments for Congenital Toxoplasmosis: A Glimpse of Hope
This study offers a glimmer of hope for preventing congenital toxoplasmosis. The findings suggest that enrofloxacin and toltrazuril could provide effective alternatives to current treatments, which often have significant side effects. It's like finding a safer path through the desert, protecting vulnerable travelers from the dangers that lie ahead.
New Treatments for Congenital Toxoplasmosis: A Glimpse of Hope
This study offers a glimmer of hope for preventing congenital toxoplasmosis. The findings suggest that enrofloxacin and toltrazuril could provide effective alternatives to current treatments, which often have significant side effects. It's like finding a safer path through the desert, protecting vulnerable travelers from the dangers that lie ahead.
Dr.Camel's Conclusion
This study is a beacon of light in the fight against toxoplasmosis. The promise of new treatments with fewer side effects offers a brighter future for both mothers and their children. It's like discovering a hidden oasis with a clear spring of clean water – a source of life and hope in a harsh desert environment.
Date :
- Date Completed 2018-04-02
- Date Revised 2022-04-08
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.